Aprevo is an FDA-designated breakthrough device that is patient-specific. It’s also designated as a transformative new device by Medicare.
“Offering Aprevo to our patients represents an important step to advancing surgical outcomes in spinal care and exemplifies our commitment to offering our patients the best care possible,” said Roland Kent, MD, co-owner of the hospital and co-founder of Northwest Specialty Hospital’s Axis Spine Center in Coeur d’Alene, Idaho.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
